Gabather AB

We develop novel drug candidates for the treatment of CNS diseases.

Gabather AB was founded in 2014, based on 10 years research at Lund University, to develop novel drug candidates for the treatment of several diseases originating in the central nervous system (CNS). Since there are several areas of unmet need as well as many medicines going off-patent, it is an opportune moment to develop new drugs targeting the CNS area.

Kategorier: Biotech

Gå till Gabather ABs hemsida